The DOI matches its Crossref record; 393 of the 393 references it cites were found in a registry or an index.
Molecular Targets for Antiepileptic Drug Development
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–393 of 393
Reciprocal regulation of P/Q-type Ca2+ channels by SNAP-25, syntaxin and synaptotagmin
Zhong, H., Yokoyama, C. T., Scheuer, T., & Catterall, W. A. (1999) · Nature Neuroscience · doi:10.1038/14721 · Cited by 167
Control of NMDA Receptor Activation by a Glycine Transporter Co-Expressed in Xenopus Oocytes
Supplisson, S., & Bergman, C. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-12-04580.1997 · Cited by 167
Molecular targets versus models for new antiepileptic drug discovery
Rogawski, M. A. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.09.012 · Cited by 165
Self-citationHAYASHI, T. (1952) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.3.46 · Cited by 165
Dodson, P. D., Billups, B., Rusznák, Z., Szucs, G., Barker, M. C., & Forsythe, I. D. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.046250 · Cited by 162
Cunningham, M. O., & Jones, R. S. G. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00051-4 · Cited by 161
Buono, R. J., Lohoff, F. W., Sander, T., Sperling, M. R., O’Connor, M. J., Dlugos, D. J., Ryan, S. G., Golden, G. T., Zhao, H., Scattergood, T. M., et al. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.02.003 · Cited by 161
Function and dysfunction of synaptic calcium channels: insights from mouse models
Pietrobon, D. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.010 · Cited by 160
Löscher, W., & Hönack, D. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22942-1 · Cited by 158
Physiological Roles and Therapeutic Potential of Metabotropic Glutamate Receptors
Conn, P. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.002 · Cited by 156
Wu, Y., Wang, W., & Richerson, G. B. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00856.2002 · Cited by 155
A model of the T-type calcium current and the low-threshold spike in thalamic neurons
Wang, X. J., Rinzel, J., & Rogawski, M. A. (1991) · Journal of Neurophysiology · doi:10.1152/jn.1991.66.3.839 · Cited by 155
Self-citationGABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence?
Wafford, K. A. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.006 · Cited by 154
Generalized epilepsy with febrile seizures plus: Mutation of the sodium channel subunit SCN1B
Wallace, R. H., Scheffer, I. E., Parasivam, G., Barnett, S., Wallace, G., Sutherland, G. R., Berkovic, S. F., & Mulley, J. C. (2002) · Neurology · doi:10.1212/wnl.58.9.1426 · Cited by 153
Köhling, R., Gladwell, S. J., Bracci, E., Vreugdenhil, M., & Jefferys, J. G. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00222-6 · Cited by 152
KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy
Rogawski, M. A. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01629-5 · Cited by 152
Self-citationBehavioural phenotypes of hypomorphic KCC2‐deficient mice
Tornberg, J., Võikar, V., Savilahti, H., Rauvala, H., & Airaksinen, M. S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03959.x · Cited by 152
Buono, R. J., Ferraro, T. N., Golden, G. T., Smith, G. G., Martin, J. F., Lohoff, F. W., Gieringer, T. A., Zamboni, D., Schwebel, C. L., Press, D. M., et al. (2004) · Mammalian Genome · doi:10.1007/s00335-003-2270-3 · Cited by 150
Madeja, M., Margineanu, D. G., Gorji, A., Siep, E., Boerrigter, P., Klitgaard, H., & Speckmann, E. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00248-x · Cited by 149
Gillard, M., Chatelain, P., & Fuks, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.022 · Cited by 148
Reddy, D. S., & Rogawski, M. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39026-3 · Cited by 148
Self-citationCrino, P. B., Jin, H., Shumate, M. D., Robinson, M. B., Coulter, D. A., & Brooks‐Kayal, A. R. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.35001.x · Cited by 148
Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability
Watanabe, H. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)81544-8 · Cited by 148
New horizons in the development of antiepileptic drugs: Innovative strategies
Löscher, W., & Schmidt, D. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.03.014 · Cited by 147
Feng, B., Tse, H., Skifter, D. A., Morley, R., Jane, D. E., & Monaghan, D. T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705644 · Cited by 147
Chapman, A. G., Nanan, K., Williams, M., & Meldrum, B. S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00242-7 · Cited by 146
Self-citationKrasowski, M. D., & Harrison, N. L. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703087 · Cited by 145
Activation mechanism of the heterodimeric GABAB receptor
Pin, J., Kniazeff, J., Binet, V., Liu, J., Maurel, D., Galvez, T., Duthey, B., Králíková, M., Blahoš, J., Prézeau, L., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.035 · Cited by 145
Reflections on Ca2+-channel diversity, 1988–1994
Tsien, R. W., Lipscombe, D., Madison, D. V., Bley, K. R., & Fox, A. P. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80015-t · Cited by 145
Anticonvulsant Actions of Gap Junctional Blockers in an In Vitro Seizure Model
Jahromi, S. S., Wentlandt, K., Piran, S., & Carlen, P. L. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.4.1893 · Cited by 145
Yamaguchi, S., Donevan, S. D., & Rogawski, M. A. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90054-b · Cited by 143
Self-citationRole of the α1G T-Type Calcium Channel in Spontaneous Absence Seizures in Mutant Mice
Song, I., Kim, D., Choi, S., Sun, M., Kim, Y., & Shin, H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5546-03.2004 · Cited by 141
The activation mechanism of class-C G-protein coupled receptors
Pin, J., Kniazeff, J., Goudet, C., Bessis, A. ‐., Liu, J., Galvez, T., Acher, F., Rondard, P., & Prézeau, L. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.03.005 · Cited by 140
Dysregulation of sodium channel expression in cortical neurons in a rodent model of absence epilepsy
Klein, J. P., Khera, D. S., Nersesyan, H., Kimchi, E. Y., Waxman, S. G., & Blumenfeld, H. (2003) · Brain Research · doi:10.1016/j.brainres.2003.11.051 · Cited by 137
Intracellular Calcium Increase in Epileptiform Activity: Modulation by Levetiracetam and Lamotrigine
Pisani, A., Bonsi, P., Martella, G., Persis, C. D., Costa, C., Pisani, F., Bernardi, G., & Calabresi, P. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.02204.x · Cited by 135
Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro
Cunningham, M. O., Woodhall, G. L., Thompson, S. E., Dooley, D. J., & Jones, R. S. G. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03625.x · Cited by 135
Keros, S., & Hablitz, J. J. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00520.2005 · Cited by 134
CLC chloride channels and transporters
Jentsch, T. J., Neagoe, I., & Scheel, O. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.002 · Cited by 134
Picard, F., Bertrand, S., Steinlein, O. K., & Bertrand, D. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00848.x · Cited by 133
Excitatory amino acids in epilepsy and potential novel therapies
Meldrum, B. S. (1992) · Epilepsy Research · doi:10.1016/0920-1211(92)90040-z · Cited by 133
Self-citationMetabotropic glutamate receptors as a strategic target for the treatment of epilepsy
Alexander, G. M., & Godwin, D. W. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.05.012 · Cited by 132
Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents
Danielsson, B. R. G., Lansdell, K., Patmore, L., & Tomson, T. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.10.002 · Cited by 130
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist
Kaminski, R. M., Banerjee, M., & Rogawski, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.010 · Cited by 129
Self-citationFujiwara‐Tsukamoto, Y., Isomura, Y., Nambu, A., & Takada, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00102-7 · Cited by 128
Pharmacology of absence epilepsy
Manning, J.-P. A., Richards, D. A., & Bowery, N. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.08.006 · Cited by 127
Effects of gap junction blockers on human neocortical synchronization
Gigout, S., Louvel, J., Kawasaki, H., D’Antuono, M., Armand, V., Kurcewicz, I., Olivier, A., Laschet, J. J., Turak, B., Devaux, B. C., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.011 · Cited by 124
Kang, M., Chen, C., Felix, R., Letts, V. A., Frankel, W. N., Mori, Y., & Campbell, K. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100787200 · Cited by 122
Bridges, R. J., Kavanaugh, M. P., & Chamberlin, A. R. (1999) · Current Pharmaceutical Design · doi:10.2174/138161280505230110101259 · Cited by 122
Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones
Wang, S., Huang, C., Hsu, K., Tsai, J.-J., & Gean, P. (1996) · Neuroreport · doi:10.1097/00001756-199611250-00048 · Cited by 121
Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity
Kanai, K., Hirose, S., Oguni, H., Fukuma, G., Shirasaka, Y., Miyajima, T., Wada, K., Iwasa, H., Yasumoto, S., Matsuo, M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000129829.31179.5b · Cited by 121
Reddy, D., & Rogawski, M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39152-9 · Cited by 121
Self-citationBehavior and Physiology of Mice Lacking the GABA A ‐Receptor δ Subunit
Spigelman, I., Li, Z., Banerjee, P., Mihalek, R., Homanics, G. E., & Olsen, R. W. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.8.x · Cited by 120
Mayer, M. L., Ghosal, A., Dolman, N. P., & Jane, D. E. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0123-06.2005 · Cited by 117
Brain-derived Neurotrophic Factor and Epilepsy—A Missing Link?
Scharfman, H. E. (2005) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7511.2005.05312.x · Cited by 117
Pais, I., Hormuzdi, S. G., Monyer, H., Traub, R. D., Wood, I. C., Buhl, E. H., Whittington, M. A., & LeBeau, F. E. N. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00549.2002 · Cited by 117
Paradoxical Reduction of Synaptic Inhibition by Vigabatrin
Overstreet, L. S., & Westbrook, G. L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.2.596 · Cited by 115
Visualization of the Domain Structure of an L-type Ca2+ Channel Using Electron Cryo-microscopy
Wolf, M., Eberhart, A., Glossmann, H. H., Striessnig, J., & Grigorieff, N. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00899-4 · Cited by 114
Selective Depression of Low–Release Probability Excitatory Synapses by Sodium Channel Blockers
Prakriya, M., & Mennerick, S. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)81203-9 · Cited by 113
Expression of the glutamate transporters in human temporal lobe epilepsy
Tessler, S., Danbolt, N. C., Faull, R. L. M., Storm‐Mathisen, J., & Emson, P. C. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00301-7 · Cited by 112
Budde, T., Caputi, L., Kanyshkova, T. G., Staak, R., Abrahamczik, C., Munsch, T., & Pape, H. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2590-05.2005 · Cited by 111
Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors
Marino, M. T., & Conn, P. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.006 · Cited by 111
ffrench-Mullen, J. M. H., Barker, J. L., & Rogawski, M. A. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03211.1993 · Cited by 110
Self-citationThe GABAA receptor gene family: new opportunities for drug development.
Whiting, P. J. (2003) · PubMed · Cited by 109
Genetic variation of CACNA1H in idiopathic generalized epilepsy
Heron, S. E., Phillips, H. A., Mulley, J. C., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20028 · Cited by 109
Ivanov, S. V., Ward, J. M., Tessarollo, L., McAreavey, D., Sachdev, V., Fananapazir, L., Banks, M. K., Morris, N. L., Djurickovic, D., Devor-Henneman, D. E., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63362-7 · Cited by 108
Self-citationOtto, J. F., Kimball, M. M., & Wilcox, K. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.4.921 · Cited by 105
Ritzén, A., Mathiesen, J. M., & Thomsen, C. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_156.x · Cited by 105
Non-competitive AMPA Antagonists of 2,3-Benzodiazepine Type
Sólyom, S., & Tarnawa, I. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612024607081 · Cited by 104
Rogawski, M. A. (2000) · Amino Acids · doi:10.1007/s007260070042 · Cited by 103
Self-citationDürmüller, N., Craggs, M. D., & Meldrum, B. S. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90016-7 · Cited by 103
Self-citationCNS Neurotransmitters and Neuromodulators: Glutamate
Stone, T. W. (1995) · Medical Entomology and Zoology · Cited by 102
Eells, J. B., Clough, R. W., Browning, R. A., & Jobe, P. C. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.015 · Cited by 102
Molecular Mechanism of AMPA Receptor Noncompetitive Antagonism
Balannik, V., Menniti, F. S., Paternain, A. V., Lerma, J., & Stern-Bach, Y. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.024 · Cited by 102
Heilstedt, H. A., Burgess, D. L., Anderson, A. E., Chedrawi, A. K., Tharp, B. R., Lee, O. W., Kashork, C. D., Starkey, D. E., Wu, Y., Noebels, J. L., et al. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.08801.x · Cited by 101
Convulsant drugs: mechanisms of action.
Dm, W. (1980) · PubMed · Cited by 101
Liu, G., Yarov-Yarovoy, V. M., Nobbs, M. S., Clare, J. J., Scheuer, T., & Catterall, W. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(02)00400-8 · Cited by 99
Kortenbruck, G., Berger, E., Speckmann, E. ‐., & Mußhoff, U. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0394 · Cited by 97
Zhong, X., Liu, J. R., Kyle, J. W., Hanck, D. A., & Agnew, W. S. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl068 · Cited by 97
Donevan, S. D., Yamaguchi, S., & Rogawski, M. A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22701-x · Cited by 96
Self-citationA crossover, add-on trial of talampanel in patients with refractory partial seizures
Chappell, A. S., Sander, J. W. A. S., Brodie, M. J., Chadwick, D., Lledó, A., Zhang, D., Bjerke, J. S., Kiesler, G. M., & Arroyo, S. (2002) · Neurology · doi:10.1212/wnl.58.11.1680 · Cited by 95
GABAA receptor epilepsy mutations
Macdonald, R. L., Gallagher, M. J., Feng, H., & Kang, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.029 · Cited by 94
Drug Treatment of Epilepsy: When Does It Fail and How to Optimize Its Use?
Kwan, P., & Brodie, M. J. (2004) · CNS Spectrums · doi:10.1017/s1092852900008476 · Cited by 92
Measuring human brain GABA in vivo
Petroff, O. A. C., & Rothman, D. L. (1998) · Molecular Neurobiology · doi:10.1007/bf02740605 · Cited by 92
Croucher, M. J., Meldrum, B. S., & Krogsgaard‐Larsen, P. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90497-1 · Cited by 92
Self-citationRole of the GABA Transporter in Epilepsy
Richerson, G. B., & Wu, Y. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-6376-8_6 · Cited by 91
Samoilova, M., Li, J., Pelletier, M. R., Wentlandt, K., Adamchik, Y., Naus, C. C. G., & Carlen, P. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01893.x · Cited by 90
Burgess, D. L., Biddlecome, G. H., McDonough, S. I., Díaz, M. E., Zilinski, C. A., Bean, B. P., Campbell, K. P., & Noebels, J. L. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0748 · Cited by 90
Felbamate block of recombinant N-methyl-d-aspartate receptors: selectivity for the NR2B subunit
Harty, T. P., & Rogawski, M. A. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(99)00108-4 · Cited by 90
Self-citationUp-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients
Notenboom, R. G. E., Hampson, D. R., Jansen, G. H., van Rijen, P. C., Veelen, C. W. M. V., van Nieuwenhuizen, O., & Graan, P. N. E. D. (2005) · Brain · doi:10.1093/brain/awh673 · Cited by 90
Bayer, K., Ahmadi, S., & Zeilhofer, H. U. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.010 · Cited by 90
G protein-coupled receptor microarrays for drug discovery
Ye, F., Lahiri, J., & Picard, L. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02779-x · Cited by 89
Ferraro, T. N., & Buono, R. J. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.04.010 · Cited by 89
Potassium channels as anti-epileptic drug targets
Wickenden, A. D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00237-x · Cited by 89
Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
Turski, L., Stephens, D., Jensen, L. H., et al. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12467-1 · Cited by 89
Niemeyer, M. I., Yusef, Y. R., Cornejo, I., Flores, C. A., Sepúlveda, F. V., & Cid, L. P. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00070.2004 · Cited by 87
Tsukada, S., Iino, M., Takayasu, Y., Shimamoto, K., & Ozawa, S. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.11.006 · Cited by 86
Otto, J. F., Yang, Y., Frankel, W. N., White, H. S., & Wilcox, K. S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1575-05.2006 · Cited by 86
Fontana, A. C. K., Guizzo, R., Beleboni, R. O., Silva, A. R. M. E., Coimbra, N. C., Amara, S. G., dos Santos, W. F., & Coutinho‐Netto, J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705352 · Cited by 86
Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam, S., Rho, J. M., Penix, L. P., Donevan, S. D., Fielding, R. P., & Rogawski, M. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09605-3 · Cited by 85
Self-citationvan Hooft, J. A., Dougherty, J. J., Endeman, D., Nichols, R. A., & Wadman, W. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02044-7 · Cited by 85
Zhang, Y., Vilaythong, A. P., Yoshor, D., & Noebels, J. L. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0992-04.2004 · Cited by 84
Bogen, I. L., Boulland, J., Mariussen, E., Wright, M., Fonnum, F., Kao, H., & Walaas, S. I. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03636.x · Cited by 83
White, H. S., Watson, W. P., Hansen, S. L., Slough, S., Perregaard, J., Sarup, A., Bolvig, T., Petersen, G., Larsson, O. M., Clausen, R. P., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068825 · Cited by 83
Vicini, S., Losi, G., & Homanics, G. E. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00126-0 · Cited by 82
Kleckner, N. W., Glazewski, J. C., Chen, C. C., & Moscrip, T. D. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38215-1 · Cited by 81
Chapman, A. G., Yip, P. K., Yap, J. S., Quinn, L. P., Tang, E., Harris, J. R., & Meldrum, B. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00014-x · Cited by 79
Self-citationMECHANISM OF THE ANTICONVULSANT ACTION OF ACETAZOLEAMIDE, A CARBONIC ANHYDRASE INHIBITOR
Millichap, J. G., Woodbury, D. M., & Goodman, L. S. (1955) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11604-2 · Cited by 76
Brown, J. T., & Randall, A. D. (2005) · Synapse · doi:10.1002/syn.20115 · Cited by 76
A Genetic Switch for Epilepsy in Adult Mice
Krestel, H. E., Shimshek, D. R., Jensen, V., Nevian, T., Kim, J., Geng, Y., Bast, T., Depaulis, A., Schönig, K., Schwenk, F., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4579-03.2004 · Cited by 75
Waldmeier, P. C., Martin, P., St�cklin, K., Portet, C., & Schmutz, M. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00178716 · Cited by 74
Sudden death in epilepsy: a wake-up call for management
Pedley, T. A., & Hauser, W. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08726-3 · Cited by 73
Excitatory Amino Acid Receptors and Their Role in Epilepsy and Cerebral Ischemia
Meldrum, B. S. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17509.x · Cited by 73
Self-citationPharmacology of GABA and Glycine Neurotransmission
Möhler, H., & Alger, B. E. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56833-6 · Cited by 71
Inhibition of vesicular glutamate storage and exocytotic release by Rose Bengal
Ogita, K., Hirata, K., Bole, D. G., Yoshida, S., Tamura, Y., Leckenby, A. M., & Ueda, T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00200.x · Cited by 71
K+ channel openers decrease seizures in genetically epileptic rats
Gandolfo, G., Romettino, S., Gottesmann, C., van Luijtelaar, G., Coenen, A. M. L., Bidard, J. N., & Lazdunski, M. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90762-0 · Cited by 70
Lingamaneni, R., & Hemmings, H. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00810-1 · Cited by 69
Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents
Hainsworth, A. H., McNaughton, N. C. L., Pereverzev, A., Schneider, T., & Randall, A. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01625-x · Cited by 69
Biagini, G., Babinski, K., Avoli, M., Marcinkiewicz, M. M., & Séguéla, P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0331 · Cited by 69
GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus
Lee, T.-S. W., Bjørnsen, L. P., Paz, C., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0017-9 · Cited by 68
Kindling‐induced overexpression of Homer 1A and its functional implications for epileptogenesis
Potschka, H., Krupp, E., Ebert, U., Gümbel, C., Leichtlein, C. B., Lorch, B., Pickert, A., Kramps, S., Young, K., Grüne, U., et al. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02265.x · Cited by 68
Löscher, W., & Hönack, D. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17146.x · Cited by 68
Spampanato, J. G., Aradi, I., Soltész, I., & Goldin, A. L. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00982.2003 · Cited by 68
Monaghan, E., McAuley, J., & Data, J. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.10.1663 · Cited by 68
Gigout, S., Louvel, J., & Pumain, R. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.12.002 · Cited by 67
Ionotropic Glutamate Receptors as Therapeutic Targets
Jellinger, K. A. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00786.x · Cited by 67
GluR5 Kainate Receptors, Seizures, and the Amygdala
Rogawski, M. A., Gryder, D. S., Castaneda, D. C., Yonekawa, W. D., BANKS, M. K., & LI, H. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07079.x · Cited by 66
Self-citationPatel, S. S., Millan, M. H., & Meldrum, B. S. (1988) · Experimental Neurology · doi:10.1016/0014-4886(88)90065-9 · Cited by 65
Self-citationShelton, R. C., Grebb, J. A., & Freed, W. J. (1987) · Brain Research · doi:10.1016/0006-8993(87)90054-0 · Cited by 65
Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons
Wang, S., Huang, C., Hsu, K., Tsai, J., & Gean, P. (1996) · Synapse · Cited by 65
He, Y., Zorumski, C. F., & Mennerick, S. J. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00225.2001 · Cited by 63
Functional Analysis of Cav3.2 T‐type Calcium Channel Mutations Linked to Childhood Absence Epilepsy
Peloquin, J. B., Khosravani, H., Barr, W., Bladen, C., Evans, R. M., Mezeyova, J., Parker, D., Snutch, T. P., McRory, J. E., & Zamponi, G. W. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00482.x · Cited by 63
The neuroprotective agent MS-153 stimulates glutamate uptake
Shimada, F., Shiga, Y., Morikawa, M., Kawazura, H., Morikawa, O., Matsuoka, T., Nishizaki, T., & Saito, N. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00735-9 · Cited by 62
The Molecular Basis of Kindling
Módy, I. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00767.x · Cited by 61
Gap Junctions, Fast Oscillations and the Initiation of Seizures
Traub, R. D., Michelson-Law, H., Bibbig, A., Buhl, E. H., & Whittington, M. A. (2004) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-6376-8_9 · Cited by 60
Emerging role of gap junctions in epilepsy.
Nemani, V. M., & Binder, D. K. (2005) · PubMed · doi:10.14670/hh-20.253 · Cited by 60
Glutamate-based therapeutic approaches: targeting the glutamate transport system
Dunlop, J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.004 · Cited by 57
Biase, D. D., Barra, D., Bossa, F., Pucci, P., & John, R. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54890-0 · Cited by 56
Rogawski, M. A., Kurzman, P. S., Yamaguchi, S.-I., & Li, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00112-x · Cited by 56
Self-citationGareri, P., Condorelli, D. F., Belluardo, N., Citraro, R., Barresi, V., TROVATOSALINATO, A., Mudò, G., Ibbadu, G. F., Russo, E., & Sarro, G. D. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.012 · Cited by 56
Peña‐Ortega, F., & Alavez-Pérez, N. S. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00369.x · Cited by 56
Kälviäinen, R. K., Halonen, T., Pitkänen, A., & Riekkinen, P. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03283.x · Cited by 55
Church, J., & McLennan, H. (1989) · The Journal of Physiology · doi:10.1113/jphysiol.1989.sp017713 · Cited by 55
GAT-3 Transporters Regulate Inhibition in the Neocortex
Kinney, G. A. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00420.2005 · Cited by 55
Recent Developments on KCNQ Potassium Channel Openers
Wua, Y.-J., & Dworetzky, S. I. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363045 · Cited by 54
Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
Subramaniam, S., Donevan, S. D., & Rogawski, M. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12245-3 · Cited by 52
Self-citationDietrich, D., Kral, T., Clusmann, H., Friedl, M., & Schramm, J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00549.x · Cited by 52
Insights from Mouse Models of Absence Epilepsy into Ca2+ Channel Physiology and Disease Etiology
Felix, R. (2002) · Cellular and Molecular Neurobiology · doi:10.1023/a:1019807719343 · Cited by 51
The Effects of Anticonvulsant Drugs on NMDA-EPSP, AMPA-EPSP, and GABA-IPSP in the Rat Hippocampus
Ko, G. Y.-P., Brown-Croyts, L. M., & Teyler, T. J. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(96)00268-7 · Cited by 50
Gilquin, B., Braud, S., Eriksson, M. A. L., Roux, B., Bailey, T. D., Priest, B. T., García, M. L., Ménèz, A., & Gasparini, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413626200 · Cited by 48
Chapman, A. G., Talebi, A., Yip, P. K., & Meldrum, B. S. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01013-5 · Cited by 47
Self-citationOtto, J. F., Yang, Y., Frankel, W., Wilcox, K., & White, H. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.65703.x · Cited by 46
Upton, N., Blackburn, T. P., Campbell, C. A., Cooper, D., Evans, M. L., Herdon, H. J., King, P. D., Ray, A. M., Stean, T. O., Chan, W. N., et al. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701330 · Cited by 46
H-channels in epilepsy: new targets for seizure control?
Chen, K., Aradi, I., Santhakumar, V., & Soltész, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02110-7 · Cited by 45
Kasper, C., Pickering, D. S., Mirza, O., Olsen, L., Kristensen, A. S., Greenwood, J. R., Liljefors, T., Schousboe, A., Wätjen, F., Gajhede, M., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.024 · Cited by 44
Rodrigues-Pinguet, N. O., Pinguet, T. J., Figl, A., Lester, H. A., & Cohen, B. N. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011155 · Cited by 42
Graves, T. D. (2006) · QJM · doi:10.1093/qjmed/hcl021 · Cited by 42
Huang, C., Huang, C., Liu, Y., & Wu, S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.58403.x · Cited by 41
Otalora, L. F. P., Couoh, J., Shigamoto, R., Zarei, M. M., & Sanabria, E. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.124 · Cited by 41
Effects of Vigabatrin on the GABAergic System as Determined by [123I]Iomazenil SPECT and GABA MRS
Verhoeff, N. P. L. G., Petroff, O. A. C., Hyder, F., Zoghbi, S. S., Fujita, M., Rajeevan, N., Rothman, D. L., Seibyl, J. P., Mattson, R. H., & Innis, R. B. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02016.x · Cited by 40
Kuo, C., Lin, B., Chang, H.-R., & Hsieh, C.-P. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.370 · Cited by 40
Langen, B., Egerland, U., Bernöster, K., Dost, R., Unverferth, K., & Rundfeldt, C. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084681 · Cited by 38
The Molecular Architecture of GABAA Receptors
Barnard, E. A. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56833-6_2 · Cited by 37
Jakus, R., Gráf, M., Andó, R. D., Balogh, B., Gacsályi, I., Lévay, G. I., Kántor, S., & Bagdy, G. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.087 · Cited by 37
The h-channel: A potential channelopathy in epilepsy?
Poolos, N. P. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.04.007 · Cited by 37
Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons
Lappin, S. C., Dale, T., Brown, J. T., Trezise, D. J., & Davies, C. H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.10.024 · Cited by 37
Proulx, É., Leshchenko, Y., Kokarovtseva, L., Khokhotva, V., El‐Beheiry, M., Snead, O. C., & Velázquez, J. L. P. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04558.x · Cited by 36
Clausen, R. P., Frølund, B., Larsson, O. M., Schousboe, A., Krogsgaard‐Larsen, P., & White, H. S. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.031 · Cited by 36
Determinants of Ictal Epileptiform Patterns in the Hippocampal Slice
Rutecki, P. A., Sayın, Ü., Yang, Y., & Hadar, E. J. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.34.x · Cited by 36
Excitatory Amino Acids and Seizures
Rogawski, M. A. (1995) · Cited by 35
Self-citationKim, D., Kwak, S., Kim, J., Won, M. H., Choi, H., Song, H., Kwon, O., Kim, Y.-I., Choi, S., & Kang, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.081 · Cited by 35
Chioza, B. A., Osei‐Lah, A. D., Wilkie, H., Nashef, L. A. M., McCormick, D., Asherson, P. J., & MAKOFF, A. J. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00195-x · Cited by 35
The Anticonvulsant Valproate Increases the Turnover Rate of γ-Aminobutyric Acid Transporters
Whitlow, R. D., Sacher, A., Loo, D. D. F., Nelson, N., & Eskandari, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207582200 · Cited by 35
Princivalle, A. P., Richards, D. A., Duncan, J. S., Spreafico, R., & Bowery, N. G. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00090-1 · Cited by 35
Decreased sensitivity to Group III mGluR agonists in the lateral perforant path following kindling
Klapstein, G. J., Meldrum, B. S., & Módy, I. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00016-7 · Cited by 34
Self-citationJones, O. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01845-9 · Cited by 34
Kamiya, Y., Andoh, T., Furuya, R., Hattori, S., Watanabe, I., Sasaki, T., Ito, H., & Okumura, F. (1999) · Anesthesiology · doi:10.1097/00000542-199906000-00028 · Cited by 33
Ilyin, V. I., Pomonis, J. D., Whiteside, G. T., Harrison, J. E., Pearson, M. S., Mark, L., Turchin, P. I., Gottshall, S. L., Carter, R. B., Nguyen, P., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104737 · Cited by 33
Russo, E., & Constanti, A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705617 · Cited by 32
Garant, D. S., Xu, S. G., Sperber, E. F., & Moshé, S. L. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00953.x · Cited by 32
1-Ethyl-2-benzimidazolinone (EBIO) suppresses epileptiform activity in in vitro hippocampus
Garduño, J., Galván, E. J., de Sevilla, D. F., & Buño, W. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.021 · Cited by 31
Gliotransmission at central glutamatergic synapses: d-serine on stage
Martineau, M., Baux, G., & Mothet, J. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.011 · Cited by 31
Groves, J. O., Guscott, M. R., Hallett, D. J., Rosahl, T. W., Pike, A. J., Davies, A. L. M., Wafford, K. A., & Reynolds, D. S. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04890.x · Cited by 28
The epileptic seizures induced by BmK I, a modulator of sodium channels
Bai, Z., Zhao, R., Zhang, X., Chen, J., Liu, T., & Ji, Y. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.09.006 · Cited by 27
Ali, A., KOLAPPAPILLAI, K., JALEESAHMAD, F., Dua, Y., IQBALKHAN, Z., & Vohora, D. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.05.003 · Cited by 25
Izzi, C., Barbon, A., Kretz, R., Sander, T., & Barlati, S. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10254 · Cited by 23
Gu, W., Sander, T., Heils, A., Lenzen, K. P., & Steinlein, O. K. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.07.003 · Cited by 22
Expression of glutamate transporters and ionotropic glutamate receptors in GLAST knockout mice
Ueda, Y., Doi, T., Tsuru, N., Tokumaru, J., & Mitsuyama, Y. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00325-x · Cited by 20
Arias, R. L., & Bowlby, M. R. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.052 · Cited by 20
Sarro, G. D., Chimirri, A., & Meldrum, B. S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02004-6 · Cited by 13
Self-citationSandoval, M. R. L., & Lebrun, I. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.09.006 · Cited by 11
Natolino, F., Zanotti, A., Contarino, A., Lipartiti, M., & Giusti, P. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00170836 · Cited by 8
Antiepileptic Drug Development
Schmidt, D. (2015) · Wiley eBooks · doi:10.1002/9781118936979.ch5 · Cited by 6
(1997) · doi:10.1002/(sici)1096-8628(19970725)74:4
Cited by
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
French, J. A., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., Curatolo, P., de Vries, P. J., Dlugos, D. J., Berkowitz, N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31419-2 · Cited by 764
Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304
French, J. A., Krauss, G. L., Biton, V., Squillacote, D., Yang, H., Laurenza, A., Kumar, D., Rogawski, M. A., Campanille, V., Floridia, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182635735 · Cited by 479
Self-citationRandomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures
Krauss, G. L., Serratosa, J. M., Villanueva, V., Endziniene, M., Hong, Z., French, J., Yang, H., Squillacote, D., Edwards, H. B., Zhu, J., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318254473a · Cited by 431
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Metadata
- Authors
- Meldrum, B. S., & Rogawski, M. A.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 4
- Issue
- 1
- Pages
- 18-61
- ISSN
- 1878-7479 (ISSN-L)
- OpenAlex
- W2065214055
- Cited by
- 468
- References
- 393
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.